Use of aclidinium in the manufacture of a medicament for use in the treatment or prevention of a respiratory disease and a pharmaceutical composition for use in the treatment or prevention of a respiratory disease or condition

Use of aclidinium in the manufacture of a medicament for use in the treatment or prevention of a respiratory disease and a pharmaceutical composition for use in the treatment or prevention of a respiratory disease or condition

  • CN 105,395,548 A
  • Filed: 01/31/2008
  • Published: 03/16/2016
  • Est. Priority Date: 02/21/2007
  • Status: Active Application
First Claim
Patent Images

1. Ah '"'"'s ammonium for by Inhalation in Treating or prevent respiratory tract disease or the patient'"'"'s condition in patient medicament preparation in purposes, wherein said patient suffer from or be sensitive to may aggravate because systemic antimuscarinic is active be selected from the following patient'"'"'s condition:

  • I. schizophrenia, visual cognitive ability obstacle, confusion, excitement, delirium, attention disappearance, memory disorder, respiration inhibition;

    Ii. glaucoma, xerophthalmia, pupil increase, blurred vision, intraocular pressure increase;

    Iii. prostate hyperplasia or obstruction, urine difficulty;

    Iv. stenosis of small intestine or obstruction, enlarged colon, chronic constipation, lower esophagus is loose, gastric motility declines, constipation;

    V. xerostomia, throat irritation, dysidria;

    Vi. cardiovascular disease (comprising any restenosis, arteriosclerosis, apoplexy or heart attack history, congestive heart failure), arrhythmia, tachycardia;

    Vii. parkinson, Alzheimer’

    s disease, dementia, andViii. myasthenia gravis;

    And/or wherein, described patient is being accepted as systemic active anticholinergic, maybe may causing or aggravate the second medicine of the agent of any patient'"'"'s condition as defined above.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×